Amended Statement of Ownership (sc 13g/a)
2016年2月10日 - 6:17AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 2)*
RBC Life Sciences, Inc. |
(Name of Issuer) |
|
COMMON STOCK |
(Title of Class of Securities) |
|
74926T201 |
(CUSIP Number) |
|
December 31, 2015 |
(Date of Event Which Requires Filing of the Statement) |
Check the appropriate box to designate
the rule pursuant to which this Schedule is filed:
The remainder of this cover page shall
be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for
any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder
of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of
1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions
of the Act (however, see the Notes).
Cusip No. 74926T201 |
13G |
Page 2 of 5 Pages |
1. |
NAME OF REPORTING PERSONS
Peter J. Abrahamson |
2. |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions)
(a)
o
(b)
o |
3. |
SEC USE ONLY
|
4. |
CITIZENSHIP OR PLACE OF ORGANIZATION
United States of America |
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH |
5.
|
SOLE VOTING POWER
184,000 |
6.
|
SHARED VOTING POWER
0 |
7.
|
SOLE DISPOSITIVE POWER
184,000 |
8.
|
SHARED DISPOSITIVE POWER
0 |
9. |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
184,000 |
10. |
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
(SEE INSTRUCTIONS)
o |
11. |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
8.3% |
12. |
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
IN |
Cusip No. 74926T201 |
13G |
Page 3 of 5 Pages |
Item 1(a). |
Name of Issuer: |
|
RBC Life Sciences, Inc. |
|
|
Item 1(b). |
Address of Issuer’s Principal Executive Offices: |
|
2301 Crown Court |
|
Irving, TX 75038 |
|
|
Item 2(a). |
Name of Person Filing: |
|
Peter J. Abrahamson |
|
|
Item 2(b). |
Address of Principal Business Office or, if none, Residence: |
|
24156 N. Coventry Ln |
|
Lake Barrington, IL 60010-7334 |
|
|
Item 2(c). |
Citizenship: |
|
United States of America |
|
|
Item 2(d). |
Title of Class of Securities: |
|
Common Stock |
|
|
Item 2(e). |
CUSIP Number: |
|
74926T201 |
|
|
Item 3. |
If this statement is filed pursuant to §§ 240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a: |
|
|
|
(a) |
o |
Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o); |
|
(b) |
o |
Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c); |
|
(c) |
o |
Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c); |
|
(d) |
o |
Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8); |
|
(e) |
o |
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E); |
|
(f) |
o |
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F); |
|
(g) |
o |
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G); |
|
(h) |
o |
A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); |
|
(i) |
o |
A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act (15 U.S.C. 80a-3); |
|
(j) |
o |
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J); |
|
(k) |
o |
Group, in accordance with § 240.13d-1(b)(1)(ii)(K). |
Cusip
No. 74926T201 |
13G |
Page 4 of 5 Pages |
Item 4. |
Ownership: |
|
Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. |
(a) |
Amount beneficially owned: 184,000 |
|
|
(b) |
Percent of class: 8.3% |
|
|
(c) |
Number of shares as to which the person has: |
|
|
|
(i) |
Sole
power to vote or to direct the vote: 184,000 |
|
|
|
|
(ii) |
Shared power to vote
or to direct the vote: 0 |
|
|
|
|
(iii) |
Sole power to dispose
or to direct the disposition of: 184,000 |
|
|
|
|
(iv) |
Shared power to
dispose or to direct the disposition of: 0 |
Item 5. |
Ownership of Five Percent or Less of a Class: |
|
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following o. |
|
|
Item 6. |
Ownership of More Than Five Percent on Behalf of Another Person: |
|
Not Applicable |
|
|
Item 7. |
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company: |
|
Not Applicable |
|
|
Item 8. |
Identification and Classification of Members of the Group: |
|
Not Applicable |
|
|
Item 9. |
Notice of Dissolution of Group: |
|
Not Applicable |
|
|
Item 10. |
Certifications: |
|
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. |
Cusip No. 74926T201 |
13G |
Page 5 of 5 Pages |
SIGNATURE
After reasonable inquiry
and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Date: |
February 9, 2016 |
|
|
|
|
|
|
|
By: |
/s/ Peter J. Abrahamson |
|
|
|
|
Name: |
Peter J. Abrahamson |
|
|
|
|
Title: |
Private Investor |
|
RBC Life Sciences (CE) (USOTC:RBCL)
過去 株価チャート
から 10 2024 まで 11 2024
RBC Life Sciences (CE) (USOTC:RBCL)
過去 株価チャート
から 11 2023 まで 11 2024
Real-Time news about RBC Life Sciences Inc (CE) (その他OTC): 0 recent articles
その他のRbc Life Sciences, Inc.ニュース記事